bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline

C502H366N18 — CID 158494405

IUPACbis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline
SMILESCC1(C)c2ccccc2N(c2cccc(-c3ccc(N(c4cc(-c5ccccc5)cc(-c5ccccc5)c4)c4cc(-c5ccccc5)cc(-c5ccccc5)c4)cc3)c2)c2ccccc21.CC1(C)c2ccccc2N(c2cccc(-c3ccc(N(c4ccc(-c5ccccc5)c(-c5ccccc5)c4)c4ccc(-c5ccccc5)c(-c5ccccc5)c4)cc3)c2)c2ccccc21.c1ccc(-c2cc(-c3ccccc3)cc(N(c3ccc(-c4cccc(N5c6ccccc6Cc6ccccc65)c4)cc3)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)c2)cc1.c1ccc(-c2cc(-c3ccccc3)cc(N(c3ccc(-c4cccc(N5c6ccccc6Cc6ccccc65)c4)cc3)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)c2)cc1.c1ccc(-c2cc(-c3ccccc3)cc(N(c3ccc(-c4cccc(N5c6ccccc6N(c6ccccc6)c6ccccc65)c4)cc3)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)c2)cc1.c1ccc(-c2ccc(N(c3ccc(-c4cccc(N5c6ccccc6Cc6ccccc65)c4)cc3)c3ccc(-c4ccccc4)c(-c4ccccc4)c3)cc2-c2ccccc2)cc1.c1ccc(-c2ccc(N(c3ccc(-c4cccc(N5c6ccccc6Cc6ccccc65)c4)cc3)c3ccc(-c4ccccc4)c(-c4ccccc4)c3)cc2-c2ccccc2)cc1.c1ccc(-c2ccc(N(c3ccc(-c4cccc(N5c6ccccc6N(c6ccccc6)c6ccccc65)c4)cc3)c3ccc(-c4ccccc4)c(-c4ccccc4)c3)cc2-c2ccccc2)cc1
InChIInChI=1S/2C66H47N3.2C63H48N2.4C61H44N2/c1-6-21-48(22-7-1)54-41-55(49-23-8-2-9-24-49)45-61(44-54)67(62-46-56(50-25-10-3-11-26-50)42-57(47-62)51-27-12-4-13-28-51)59-39-37-52(38-40-59)53-29-20-32-60(43-53)69-65-35-18-16-33-63(65)68(58-30-14-5-15-31-58)64-34-17-19-36-66(64)69;1-6-21-49(22-7-1)59-43-41-57(46-61(59)51-25-10-3-11-26-51)67(58-42-44-60(50-23-8-2-9-24-50)62(47-58)52-27-12-4-13-28-52)55-39-37-48(38-40-55)53-29-20-32-56(45-53)69-65-35-18-16-33-63(65)68(54-30-14-5-15-31-54)64-34-17-19-36-66(64)69;1-63(2)59-30-15-17-32-61(59)65(62-33-18-16-31-60(62)63)56-29-19-28-50(40-56)49-34-36-55(37-35-49)64(57-41-51(45-20-7-3-8-21-45)38-52(42-57)46-22-9-4-10-23-46)58-43-53(47-24-11-5-12-25-47)39-54(44-58)48-26-13-6-14-27-48;1-63(2)59-30-15-17-32-61(59)65(62-33-18-16-31-60(62)63)52-29-19-28-50(42-52)45-34-36-51(37-35-45)64(53-38-40-55(46-20-7-3-8-21-46)57(43-53)48-24-11-5-12-25-48)54-39-41-56(47-22-9-4-10-23-47)58(44-54)49-26-13-6-14-27-49;2*1-5-18-44(19-6-1)52-37-53(45-20-7-2-8-21-45)41-58(40-52)62(59-42-54(46-22-9-3-10-23-46)38-55(43-59)47-24-11-4-12-25-47)56-34-32-48(33-35-56)49-28-17-29-57(39-49)63-60-30-15-13-26-50(60)36-51-27-14-16-31-61(51)63;2*1-5-18-45(19-6-1)56-38-36-54(42-58(56)47-22-9-3-10-23-47)62(55-37-39-57(46-20-7-2-8-21-46)59(43-55)48-24-11-4-12-25-48)52-34-32-44(33-35-52)49-28-17-29-53(41-49)63-60-30-15-13-26-50(60)40-51-27-14-16-31-61(51)63/h2*1-47H;2*3-44H,1-2H3;2*1-35,37-43H,36H2;2*1-39,41-43H,40H2
InChIKeyHJCFPAZPFCTVKE-UHFFFAOYSA-N
MW6650.58 g/mol
LogP140.15
Rot. Bonds74

About bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline

bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline (PubChem CID 158494405) has the molecular formula C502H366N18 and a molecular weight of 6650.58 g/mol. Its IUPAC name is bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline.

Molecular Properties

Compound Namebis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline
PubChem CID158494405
Molecular FormulaC502H366N18
Molecular Weight6650.58 g/mol
Exact Mass6644.92
IUPAC Namebis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline
SMILESCC1(C)c2ccccc2N(c2cccc(-c3ccc(N(c4cc(-c5ccccc5)cc(-c5ccccc5)c4)c4cc(-c5ccccc5)cc(-c5ccccc5)c4)cc3)c2)c2ccccc21.CC1(C)c2ccccc2N(c2cccc(-c3ccc(N(c4ccc(-c5ccccc5)c(-c5ccccc5)c4)c4ccc(-c5ccccc5)c(-c5ccccc5)c4)cc3)c2)c2ccccc21.c1ccc(-c2cc(-c3ccccc3)cc(N(c3ccc(-c4cccc(N5c6ccccc6Cc6ccccc65)c4)cc3)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)c2)cc1.c1ccc(-c2cc(-c3ccccc3)cc(N(c3ccc(-c4cccc(N5c6ccccc6Cc6ccccc65)c4)cc3)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)c2)cc1.c1ccc(-c2cc(-c3ccccc3)cc(N(c3ccc(-c4cccc(N5c6ccccc6N(c6ccccc6)c6ccccc65)c4)cc3)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)c2)cc1.c1ccc(-c2ccc(N(c3ccc(-c4cccc(N5c6ccccc6Cc6ccccc65)c4)cc3)c3ccc(-c4ccccc4)c(-c4ccccc4)c3)cc2-c2ccccc2)cc1.c1ccc(-c2ccc(N(c3ccc(-c4cccc(N5c6ccccc6Cc6ccccc65)c4)cc3)c3ccc(-c4ccccc4)c(-c4ccccc4)c3)cc2-c2ccccc2)cc1.c1ccc(-c2ccc(N(c3ccc(-c4cccc(N5c6ccccc6N(c6ccccc6)c6ccccc65)c4)cc3)c3ccc(-c4ccccc4)c(-c4ccccc4)c3)cc2-c2ccccc2)cc1
InChIInChI=1S/2C66H47N3.2C63H48N2.4C61H44N2/c1-6-21-48(22-7-1)54-41-55(49-23-8-2-9-24-49)45-61(44-54)67(62-46-56(50-25-10-3-11-26-50)42-57(47-62)51-27-12-4-13-28-51)59-39-37-52(38-40-59)53-29-20-32-60(43-53)69-65-35-18-16-33-63(65)68(58-30-14-5-15-31-58)64-34-17-19-36-66(64)69;1-6-21-49(22-7-1)59-43-41-57(46-61(59)51-25-10-3-11-26-51)67(58-42-44-60(50-23-8-2-9-24-50)62(47-58)52-27-12-4-13-28-52)55-39-37-48(38-40-55)53-29-20-32-56(45-53)69-65-35-18-16-33-63(65)68(54-30-14-5-15-31-54)64-34-17-19-36-66(64)69;1-63(2)59-30-15-17-32-61(59)65(62-33-18-16-31-60(62)63)56-29-19-28-50(40-56)49-34-36-55(37-35-49)64(57-41-51(45-20-7-3-8-21-45)38-52(42-57)46-22-9-4-10-23-46)58-43-53(47-24-11-5-12-25-47)39-54(44-58)48-26-13-6-14-27-48;1-63(2)59-30-15-17-32-61(59)65(62-33-18-16-31-60(62)63)52-29-19-28-50(42-52)45-34-36-51(37-35-45)64(53-38-40-55(46-20-7-3-8-21-46)57(43-53)48-24-11-5-12-25-48)54-39-41-56(47-22-9-4-10-23-47)58(44-54)49-26-13-6-14-27-49;2*1-5-18-44(19-6-1)52-37-53(45-20-7-2-8-21-45)41-58(40-52)62(59-42-54(46-22-9-3-10-23-46)38-55(43-59)47-24-11-4-12-25-47)56-34-32-48(33-35-56)49-28-17-29-57(39-49)63-60-30-15-13-26-50(60)36-51-27-14-16-31-61(51)63;2*1-5-18-45(19-6-1)56-38-36-54(42-58(56)47-22-9-3-10-23-47)62(55-37-39-57(46-20-7-2-8-21-46)59(43-55)48-24-11-4-12-25-48)52-34-32-44(33-35-52)49-28-17-29-53(41-49)63-60-30-15-13-26-50(60)40-51-27-14-16-31-61(51)63/h2*1-47H;2*3-44H,1-2H3;2*1-35,37-43H,36H2;2*1-39,41-43H,40H2
InChIKeyHJCFPAZPFCTVKE-UHFFFAOYSA-N
XLogP140.15
TPSA58.32 Ų
H-Bond Donors
H-Bond Acceptors18
Rotatable Bonds74
Heavy Atoms520
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5006650.58
LogP ≤ 5140.15
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1018

Analyze bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline?
The IUPAC name of bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline (CID 158494405) is bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline.
What is the SMILES notation for bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline?
The canonical SMILES for bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline is CC1(C)c2ccccc2N(c2cccc(-c3ccc(N(c4cc(-c5ccccc5)cc(-c5ccccc5)c4)c4cc(-c5ccccc5)cc(-c5ccccc5)c4)cc3)c2)c2ccccc21.CC1(C)c2ccccc2N(c2cccc(-c3ccc(N(c4ccc(-c5ccccc5)c(-c5ccccc5)c4)c4ccc(-c5ccccc5)c(-c5ccccc5)c4)cc3)c2)c2ccccc21.c1ccc(-c2cc(-c3ccccc3)cc(N(c3ccc(-c4cccc(N5c6ccccc6Cc6ccccc65)c4)cc3)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)c2)cc1.c1ccc(-c2cc(-c3ccccc3)cc(N(c3ccc(-c4cccc(N5c6ccccc6Cc6ccccc65)c4)cc3)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)c2)cc1.c1ccc(-c2cc(-c3ccccc3)cc(N(c3ccc(-c4cccc(N5c6ccccc6N(c6ccccc6)c6ccccc65)c4)cc3)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)c2)cc1.c1ccc(-c2ccc(N(c3ccc(-c4cccc(N5c6ccccc6Cc6ccccc65)c4)cc3)c3ccc(-c4ccccc4)c(-c4ccccc4)c3)cc2-c2ccccc2)cc1.c1ccc(-c2ccc(N(c3ccc(-c4cccc(N5c6ccccc6Cc6ccccc65)c4)cc3)c3ccc(-c4ccccc4)c(-c4ccccc4)c3)cc2-c2ccccc2)cc1.c1ccc(-c2ccc(N(c3ccc(-c4cccc(N5c6ccccc6N(c6ccccc6)c6ccccc65)c4)cc3)c3ccc(-c4ccccc4)c(-c4ccccc4)c3)cc2-c2ccccc2)cc1.
What is the InChIKey of bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline?
The InChIKey is HJCFPAZPFCTVKE-UHFFFAOYSA-N. The full InChI is InChI=1S/2C66H47N3.2C63H48N2.4C61H44N2/c1-6-21-48(22-7-1)54-41-55(49-23-8-2-9-24-49)45-61(44-54)67(62-46-56(50-25-10-3-11-26-50)42-57(47-62)51-27-12-4-13-28-51)59-39-37-52(38-40-59)53-29-20-32-60(43-53)69-65-35-18-16-33-63(65)68(58-30-14-5-15-31-58)64-34-17-19-36-66(64)69;1-6-21-49(22-7-1)59-43-41-57(46-61(59)51-25-10-3-11-26-51)67(58-42-44-60(50-23-8-2-9-24-50)62(47-58)52-27-12-4-13-28-52)55-39-37-48(38-40-55)53-29-20-32-56(45-53)69-65-35-18-16-33-63(65)68(54-30-14-5-15-31-54)64-34-17-19-36-66(64)69;1-63(2)59-30-15-17-32-61(59)65(62-33-18-16-31-60(62)63)56-29-19-28-50(40-56)49-34-36-55(37-35-49)64(57-41-51(45-20-7-3-8-21-45)38-52(42-57)46-22-9-4-10-23-46)58-43-53(47-24-11-5-12-25-47)39-54(44-58)48-26-13-6-14-27-48;1-63(2)59-30-15-17-32-61(59)65(62-33-18-16-31-60(62)63)52-29-19-28-50(42-52)45-34-36-51(37-35-45)64(53-38-40-55(46-20-7-3-8-21-46)57(43-53)48-24-11-5-12-25-48)54-39-41-56(47-22-9-4-10-23-47)58(44-54)49-26-13-6-14-27-49;2*1-5-18-44(19-6-1)52-37-53(45-20-7-2-8-21-45)41-58(40-52)62(59-42-54(46-22-9-3-10-23-46)38-55(43-59)47-24-11-4-12-25-47)56-34-32-48(33-35-56)49-28-17-29-57(39-49)63-60-30-15-13-26-50(60)36-51-27-14-16-31-61(51)63;2*1-5-18-45(19-6-1)56-38-36-54(42-58(56)47-22-9-3-10-23-47)62(55-37-39-57(46-20-7-2-8-21-46)59(43-55)48-24-11-4-12-25-48)52-34-32-44(33-35-52)49-28-17-29-53(41-49)63-60-30-15-13-26-50(60)40-51-27-14-16-31-61(51)63/h2*1-47H;2*3-44H,1-2H3;2*1-35,37-43H,36H2;2*1-39,41-43H,40H2.
What are the key properties of bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline?
bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline has a molecular weight of 6650.58 g/mol, XLogP of 140.15, 74 rotatable bonds, 0 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline is sourced from PubChem (CID 158494405), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).